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Abstract 
 
Post-intubation airway related adverse effects such as coughing on the endotracheal tube (ETT), restlessness, 
hoarseness and sore throat are common and undesirable outcomes of anaesthesia using endotracheal intubation. 
This prospective randomized single blind study was carried out to compare the effectiveness of intra-cuff 
dexamethasone and alkalinized lignocaine in reducing the incidence of post-intubation airway related adverse 
effects. Eighty four patients aged 18 – 60 years, of ASA status I or II, were randomly allocated into three 
groups: air, dexamethasone and alkalinized lignocaine. Their ETT cuffs were inflated according to the group 
they were allocated to. The incidence of coughing on the ETT, restlessness, hoarseness and sore throat was 
assessed, postoperatively. The results showed a significant difference in the incidence of cough, restlessness, 
hoarseness and sore throat in the dexamethasone group compared to the air group. All the patients had minimal 
or no sore throat at all documented times. Both intra-cuff dexamethasone and alkalinized lignocaine 
significantly reduced the incidence of hoarseness. However, alkalinized lignocaine additionally lowered the 
incidence of restlessness, significantly. 
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Introduction 
 
Endotracheal intubation is the definitive method of 
securing the airway during general anaesthesia. It 
facilitates positive pressure ventilation and confers 
protection of the airway from aspiration of gastric 
content. However, endotracheal intubation has been 
known to cause post-intubation airway related 
adverse effects, which include post-operative 
coughing on the tube, restlessness, hoarseness and 
sore throat. The latter, although regarded as a minor 
complication, is often distressing for the patient and 
remains as an unpleasant post-operative memory. 
The incidence of sore throat ranges from 14.4 to 
50% (1). Post-intubation airway related adverse 
effects may result in laryngospasm, tachycardia, 
hypertension, cardiac ischemia, bleeding, increased 
intracranial and intraocular pressures which may 
impose serious implications on patients, thus the 
importance in preventing its occurrence (2).  
It was postulated that post-intubation airway related 
adverse effects were due to irritation and 
inflammation of the airway, which may occur 
during intubation, as insertion of an endotracheal 
tube (ETT) may irritate or damage the mucosal 
tissue, causing oedema and inflammation (3). The 
risks are increased if intubation was particularly 
difficult or traumatic. It has also been proposed that 
the incidence and severity of sore throat post- 
intubation is highly correlated to the endotracheal 
cuff design, in particular the cuff-trachea contact 
area (4). Low-pressure high-volume cuffs cause a 
larger area of trachea mucosal erosion compared to 
high-pressure low-volume cuffs (5). Over-inflation 
of ETT cuffs, resulting in high cuff pressures, has 
also been associated with trachea mucosal damage, 
and exacerbation of post-intubation airway related 
adverse effects (6). Cuff pressures above 39 cm H2O 
are shown to reduce trachea mucosal 
microcirculation (7). As a cuffed ETT is inevitable 
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in certain cases, the potential airway irritation and 
inflammation associated with its use may be 
minimized by ensuring a swift and smooth 
intubation, and monitoring intra-cuff pressure. 
 
Alkalinized lignocaine (lignocaine hydrochloride in 
8.4% sodium bicarbonate) administered intra-cuff 
has repeatedly been shown to reduce the incidence 
of post-intubation airway related adverse effects 
(8,9).  Lignocaine exerts its local anaesthetic action 
by inhibiting the ionic fluxes needed for the 
initiation and conduction of impulses, thus 
stabilizing the neuronal membrane (10). It also 
limits the potential damage to the tracheal mucosa 
by suppressing ‘bucking’ on the ETT (8). Sodium 
bicarbonate on the other hand alkalinizes lignocaine 
hydrochloride and increases its diffusing capacity 
through the hydrophobic ETT cuff membrane (9). 
However, as lignocaine hydrochloride does not 
possess any anti-inflammatory action, its exact 
mechanism in preventing post-operative sore throat 
is still unknown (11). 
 
Corticosteroids are known for their anti-
inflammatory actions. Their mechanism of action is 
thought to be by inducing lipocortins which are 
phospholipase A2 inhibitory proteins. These 
proteins are thought to be responsible in inhibiting 
the release of arachidonic acid, the common 
precursor of potent mediators of inflammation, such 
as prostaglandins and leukotrienes (12). By reducing 
or inhibiting the inflammatory response, it should be 
possible to reduce the incidence of post-operative 
cough, restlessness, hoarseness and sore throat. 
Studies using topically applied steroid, intravenous 
dexamethasone and inhaled fluticasone propionate 
have shown favourable results in reducing post-
operative sore throat (3,11,13,14). Based on the 
above studies using steroids, we postulate that intra-
cuff dexamethasone may reduce the incidence of 
post-intubation airway related adverse effects by its 
diffusion through the ETT cuff and subsequent anti-
inflammatory action on the tracheal mucosa. The 
objective of this study was to compare the 
effectiveness of intra-cuff dexamethasone versus 
alkalinized lignocaine with intra-cuff air as a control 
group, in reducing post-intubation airway related 
adverse effects. 
 
Materials and Methods 
 
This was a prospective randomized, single-blind 
controlled study. Following institutional ethics 
approval, 90 patients were recruited. Patients were 
aged between 18 and 60 years, with American 
Society of Anaesthesiologists (ASA) status class I or 
II, scheduled for surgery lasting between 30 to 360 
mins, under general anaesthesia with endotracheal 
intubation. Exclusion criteria were those undergoing 
surgery of the oral cavity and pharynx, with 
anticipated difficult airway, requiring the use of 
nasogastric tubes and throat packs, with pre-existing 
upper respiratory tract infections, sore throat, 
hoarseness and those on steroid therapy.  
 
Pre-anaesthetic assessments of the patients were 
done a day prior to their surgery. The study protocol 
was explained and written informed consent taken. 
Using computer generated randomised numbers, 
patients were randomized into one of three groups; 
air, dexamethasone or alkalinized lignocaine group. 
Patients were premedicated with oral midazolam 7.5 
mg upon call to the operating theatre (OT). In the 
OT, standard monitoring included non-invasive 
blood pressure monitoring, pulse oximetry, 
electrocardiogram and capnograph. After 
intravenous (IV) access was obtained, the patient 
was pre-oxygenated with 100% oxygen for three 
minutes, followed by IV induction with fentanyl 2 
mcg/kg, propofol 2 mg/kg and rocuronium 0.6 
mg/kg. Single use polyvinyl chloride ETTs 
(Portex® Profile tracheal tube) with low-pressure-
high-volume cuffs, of inner diameter size 7.0-7.5 
mm for females and 8.0-8.5 mm for males were 
used.  The ETT was lubricated with sterile water 
and intubations performed by anaesthetic doctors 
with at least one year of experience in anaesthesia. 
Direct laryngoscopy was performed using either a 
Macintosh 3 or 4 laryngoscope blade followed by 
intubation.  The ETT cuff was inflated according to 
the randomised protocol. The ETT cuffs in the air, 
dexamethasone and lignocaine groups were inflated 
with air, 2 ml (8 mg) of dexamethasone, or 2 ml 
(2%) lignocaine respectively. An additional 2-3 ml 
of saline or 8.4% sodium bicarbonate was added 
into the dexamethasone and alkalinized lignocaine 
groups respectively, till no leak was audible at an 
intra-airway pressure of 20cm H2O. The initial cuff 
pressure was measured and recorded with a 
Mallinckrodt cuff pressure gauge (Mallinckrodt 
Medical, Athlone, Ireland). Patients who had 
intubation unsuccessful on the first attempt, were 
excluded. Anaesthesia was then maintained with a 
50% oxygen-air mixture and sevoflurane, titrated to 
achieve a MAC of 1-1.3. Neuromuscular blockade 
was monitored and additional rocuronium doses 
given to maintain a train-of-four (TOF) count of 
zero. 
 
At the end of the surgery, the cuff pressure was 
again measured and recorded. Sevoflurane was 
discontinued, 100% oxygen was administered and 
residual neuromuscular blockade antagonized with 
atropine 0.02 mg/kg and neostigmine 0.05 mg/kg 
when at least 3 train-of-four twitches were present. 
Oral suctioning was done with care under direct 
vision just before extubation. Upon fulfilling 
extubation criteria (TOF ratio at least 90%, regular 
spontaneous ventilation present and able to follow 
verbal commands) the patient was extubated and 
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100% oxygen was administered via face mask. The 
patient was assessed by the attending anaesthetist 
for coughing on the ETT, restlessness before 
extubation and hoarseness in the recovery area 
before discharge. The severity of post-extubation  
sore throat was evaluated  with the visual analogue 
score scale (VAS, 0-100 mm)  at 30 minutes, in the 
recovery room, and at 2 and 24 hours in the ward. 
Based on previous studies’, sample size was 
calculated using nQuery Advisor version 6.01 
Software (2,4), 25 patients were required in each 
group to permit a type I error of α = 0.05, type II 
error of β = 0.05 and power of 95%. Considering a 
drop-out rate of 20%, 30 patients were required in 
each group. Statistical analysis was performed using 
SPSS Statistic version 17.0. Data was tested using 
analysis of variance (ANOVA) and non-parametric 
test was used to assess cough, restlessness, 
hoarseness and sore throat. A p value < 0.05 was 
considered statistically significant. 
 
Results  
 
Ninety patients were enrolled in this study. 
However, six patients were excluded, of which four 
required more than one intubation attempt and two 
patients had surgery exceeding six hours. The 
patients’ demographic and perioperative details 
were comparable between groups (Table1).  
 
The volume of intra-cuff media required to prevent 
leak around the ETT in the air group was more but 
not statistically significant. Between the 
dexamethasone and lignocaine hydrochloride 
groups, intra-cuff volumes were comparable. There 
were no significant changes from the initial volumes 
of the intra-cuff media in all three groups at the end 
of anaesthesia. The pressure required to prevent leak 
around the ETT in all three groups were 
comparable.  There were no significant changes 
from the initial cuff pressures in all three groups at 
the end of the anaesthesia (Table2). 
 
Comparing the three groups, the incidence of 
coughing on the ETT was less but not statistically 
significant in the dexamethasone and alkalinized 
lignocaine groups compared to the air group. The 
incidence of restlessness was lower in the 
dexamethasone and alkalinized lignocaine groups, 
but only statistically significant in the alkalinized 
lignocaine group. The incidence of hoarseness was 
also lower in the dexamethasone and alkalinized 
lignocaine groups compared to the air group, and 
this was statistically significant. However, between 
the dexamethasone and lignocaine hydrochloride 
groups, the incidence of coughing, restlessness and 
hoarseness was comparable (Table3). 
 
The mean VAS scores for sore throat in the 
dexamethasone and alkalinized lignocaine groups  
were lower compared to the air group but this was 
statistically significant only at 2 and 24 hour scores, 
in the ward. Between the dexamethasone and 
lignocaine hydrochloride groups, the mean VAS 
scores were comparable at all documented times 
(Table 4). 
 
Discussion 
 
The over-inflation of ETT cuffs with high intra-cuff 
volumes, either at initial cuff inflation post-
intubation and/or at the end of surgery results in 
high intra-cuff pressures which may result in 
undesirable airway adverse events. The present 
study showed insignificant changes from the initial 
pressure and volume of the ETT cuffs, at the end of 
anaesthesia. This was in contrast to Shroff and 
Patil’s (2009) and Combes’ et al. (2001) where 
statistically significant increments in intra-cuff 
pressures were observed in the air group (2,6). This 
may be due to the fact that in this study, anaesthesia 
was maintained with an oxygen air mixture, whereas 
in the mentioned prior studies, an oxygen and 
nitrous oxide mixture was used. In the blood, nitrous 
oxide is 34 times more soluble than nitrogen. The 
diffusion of nitrous oxide into the cuff is facilitated 
by the blood/gas solubility coefficient of 
0.468/0.013 for nitrous oxide/nitrogen. The cuff 
pressure is increased as nitrous oxide diffuses into 
the air filled cuff more quickly than it leaves the 
cuff (2).  
 
This study also showed that higher volumes and 
pressures were required to prevent any leak around 
the ETT when air was used as the inflation media as 
compared to liquid, such as dexamethasone and 
alkalinized lignocaine. Shroff and Patil (2009) and 
Estebe et al. (2002 & 2005) in their studies 
demonstrated that intra-cuff alkalinized lignocaine 
and saline significantly reduced the incidence of 
post-intubation airway related adverse effects 
compared to air. This was possibly due to the intra-
operative accumulation of intra-cuff nitrous oxide in 
the air group which was evident at the end of 
anaesthesia (2,8,9). Inflating the ETT cuffs with 
liquids obliterates air pockets in the ETT cuffs and 
confers added benefit by preventing excessive intra-
cuff pressures (9). 
 
The incidence of coughing in our study was lower 
but not statistically significant in the dexamethasone 
and alkalinized lignocaine groups. The incidence of 
coughing in the air group was higher in the studies 
done by Estebe et al. (2002 & 2005) (70% and 
96%), as compared to our study (43%). This could 
be explained by their usage of nitrous oxide, thus 
the resultant higher intra-cuff pressure at the end of 
anaesthesia (8,9). In the same study, intra-cuff 
alkalinized lignocaine reduced the incidence of 
coughing by 56%-65% compared to air group (8,9).  
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Table 1: Demographic and perioperative data. Data are presented as mean SD or number (%) as appropriate. 
 
Variables 
Air 
( n = 28 ) 
Dexamethasone 
( n = 28 ) 
Alkalinized lignocaine 
( n = 28 ) 
Age (year) 44 ± 12 41 ±13 47±10 
Sex (Male /Female) 15 / 13 17 /11 15 /13 
Weight (kg) 66 ± 10 65 ± 10 66 ± 10 
Height (cm) 166 ± 7 165 ± 8 167 ± 6 
Duration of anaesthesia (minute) 126 ± 77 124 ± 81 103 ± 63 
Smoker 8 (28%) 10 (35%) 10 (35%) 
 
 
Table 2: Volume of intra-cuff media and intra-cuff pressure at the start and end of anaesthesia.Data are presented as mean ± 
SD. 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3: Incidence of cough, restlessness and hoarseness at emergence.  Data are presented as number (%) 
 
Variables Air Dexamethasone Alkalinized lignocaine 
Cough 20 (43.5) 14 (30.4) 12 (26.1) 
Restlessness 8 (72.7) 2 (18.2)+ 1 (9.1)#+ 
Hoarseness 7 (77.8) 1 (11.1)*+ 1 (11.1)#+ 
*p < 0.05 between group air vs dexamethasone 
#p < 0.05 between group air vs alkalinized lignocaine 
+ with Yates’ correction 
 
 
Table 4:  Visual analog scale (VAS) score for sore throat at different time intervals. Data are presented as mean ± SD. 
 
 
 
 
 
 
 
 
 
 
 
In our study, alkalinized lignocaine reduced the 
incidence of coughing by 40% compared to air 
group. In Shroff and Patil’s (2009) study, the 
incidence of restlessness was 72% and 20%; and 
hoarseness 78% and 32%, in the air and alkalinized 
lignocaine groups respectively (2). The incidence of 
restlessness and hoarseness was significantly lower 
in the alkalinized lignocaine groups in Shroff and 
Patil’s and our study (2). The incidence of 
restlessness and hoarseness in our study was also 
lower in dexamethasone group compared to air 
group, although only hoarseness was significantly 
reduced. 
 
The incidence of sore throat in the air group in this 
study was 43% which was comparable to that found 
in a study by Biro et al. (2005) (1). There was 
minimal or no complain of sore throat in the 
Volume and Pressure 
Air 
(n = 28) 
Dexamethasone 
(n = 28) 
Alkalinized lignocaine 
(n = 28) 
Volume: 
Start of anaesthesia (ml) 
7.3 ± 0.7 4.9 ± 0.5 4.8 ±0.5 
End of anaesthesia (ml) 7.2 ± 0.8 4.8 ± 0.5 4.7 ± 0.6 
Pressure:  
Start of anaesthesia (cm H2O) 
26.0 ±1.0 23.0 ± 0.9 24.0 ± 1.1 
End of anaesthesia (cm H2O) 25.0 ±1.0 23.0 ± 1.1 23.0 ± 1.0 
Time Interval 
Air 
(n = 28) 
Dexamethasone 
(n = 28) 
Alkalinized lignocaine 
(n = 28) 
30 minutes 11 ± 13 4 ± 8 3 ± 7 
2 hours 8 ± 10 0 ± 1* 1 ± 4# 
24 hours 1 ± 4 0* 0# 
*p < 0.05 between group air vs dexamethasone 
#p < 0.05 between group air vs alkalinized lignocaine 
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dexamethasone and alkalinized lignocaine groups at 
2 and 24 hours post-operatively, and this was 
statistically significant compared to the air group. 
The intensity of sore throat for all three groups in 
this study was mild and similar to that reported by 
Estebe et al. (2005) (9). The ability of lignocaine to 
diffuse out of ETT cuffs was first described by 
Sconzo et al. (1990) (15). Estebe et al. (2002) 
showed increased diffusion of lignocaine when it 
was alkalinized and plasma lignocaine level was 
detected in the venous blood samples of patients 
who had their ETT cuff inflated with alkalinized 
lignocaine. Lignocaine diffusion was possible as the 
ETT cuff is semi-permeable, thus making it a 
potential drug reservoir (8).  
 
Ayoub et al. (1998) showed that topical application 
of betamethasone over the ETT reduced the 
incidence of cough, hoarseness and sore throat post-
operatively (3). Park et al. (2008) administered 
prophylactic intravenous dexamethasone with 
double lumen intubation and found a decrease in the 
incidence and severity of sore throat and hoarseness 
post extubation (13). Tazeh-kand et al. (2010) found 
that inhaled fluticasone propionate given pre-
induction decreased the incidence and severity of 
post-operative cough, sore throat and hoarseness 
(14). Steroids with their anti-inflammatory action 
has been attributed to these outcomes (11,13,14). In 
this study it could be possible that dexamethasone 
diffused through the ETT cuff, acting on the tracheal 
mucosa in contact with it, thus reducing the 
inflammatory process occurring in the tracheal 
mucosa. Measurement and detection of 
dexamethasone levels in venous blood samples of 
patients who had their ETTs inflated with 
dexamethasone might have confirmed this. 
Alkalinized lignocaine on the other hand diffuses 
through and anaesthetizes the tracheal mucosa in 
contact with the cuff, and reduces the firing of their 
irritant receptors (14). These two mechanisms are 
most probably responsible for the observed 
reduction in the incidence of coughing on the ETT, 
restlessness, hoarseness, and sore throat in the 
postoperative period. In conclusion, both intra-cuff 
dexamethasone and alkalinized lignocaine 
significantly reduced the incidence of hoarseness, 
however alkalinized lignocaine additionally lowered 
the incidence of restlessness significantly. All the 
patients had minimal or no sore throat at all 
documented times. 
 
References 
 
1. Biro P, Seifert B, Pasch T. Complaints of sore 
throat after tracheal intubation: a prospective 
evaluation. Eur J Anaesthesiol 2005;22(4):307-
311. 
 
2. Shroff P, Patil V. Efficacy of cuff inflation 
media to prevent postintubation-related 
emergence phenomena: air, saline and 
alkalinized lignocaine. Eur J Anaesthesiol 
2009;26(6):458-462. 
 
3. Ayoub MC, Ghobashy A, McGrimely L, et al. 
Wide spread application of topical steroids to 
decrease sore throat, hoarseness and cough 
after tracheal intubation. Anesth Analg 
1998;87(3):714-716. 
 
4. McHardy FE, Chung F. Postoperative sore 
throat: cause, prevention and treatment. 
Anaesthesia 1999;54(5):444-453. 
 
5. Mandoe H, Nikolajsen L, Lintrup U, Jepsen D, 
Moolgaard J.  Sore throat after endotracheal 
intubation. Anesth Analg 1992;74(6):897-900. 
 
6. Combes X, Schauvliege  F, Peyrouset O, et al. 
Intracuff pressure and tracheal morbidity: 
influence of filling with saline during nitrous 
oxide anesthesia. Anesthesiology 
2001;95(5):1120-1124. 
 
7. Loeser EA, Hodges M, Gliedman J, Stanley 
TH, Johansen RK, Yonetani D. Tracheal 
pathology following short term intubation with 
low and high pressure endotracheal tube cuffs. 
Anesth Analg 1978;57(5):577-579. 
 
8. Estebe JP, Dollo G, Le Corre P, et al. 
Alkalinization of intracufflidocaine improves 
endotracheal tube-induced emergence 
phenomena. Anesth Analg 2002;94(1):227-
230. 
 
9. Estebe JP, Gentili M, Le Corre P, Dollo G, 
Chevanne F, Ecoffey C.Alkalinization of 
intracufflidocaine: efficacy and safety. Anesth 
Analg 2005;101(5):1536-1541. 
 
10. Stoelting RK, Hillier SC. Pharmacology & 
Physiology in Anesthetic Practice. 4th ed - 
Local anesthetics. Philadelphia: Lippincott 
Williams & Wilkins, 2006, pp-181-182. 
 
11. Sumathi PA, Shenoy T, Ambareesha M, 
Krishna HM. Controlled comparison between 
betamethasone gel and lidocaine jelly applied 
over tracheal tube to reduce postoperative sore 
throat, cough, and hoarseness of voice. Br J 
Anaesth 2008;100(2):215-218. 
 
12. Stoelting RK, Hillier SC. Pharmacology & 
Physiology in Anesthetic Practice.4th ed.- 
Hormones and Drugs. Philadelphia: Lippincott 
Williams & Wilkins, 2006, pp-461-465. 
 
Intra-cuff dexamethasone vs lignocaine                                                                                                             Kep Kee W et al. 
Journal of Surgical Academia 2013; 3(2):26-31   31 
 
13. Park SH, Han SH, Do SH, Kim JW, Rhee KY, 
Kim JH. Prophylactic dexamethasone 
decreases the incidence of sore throat and 
hoarseness after tracheal extubation with a 
double-lumen endobronchial tube. Anesth 
Analg 2008;107(6):1814-1818. 
 
14. Tazeh-kand NF, Eslami B, Mohammadian K. 
Inhaled fluticasone propionate reduces 
postoperative sore throat, cough and 
hoarseness. Anesth Analg 2010;111(4):895-
889. 
 
15. SconzoJM, Moscicki JC, Difazio CA. In vitro 
diffusion of lidocaine across endotracheal tube 
cuffs. Reg Anesth 1990;15(1):37-40. 
